Latest news
Loading news…
Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.
Terns Pharmaceuticals on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Terns Pharmaceuticals was acquired by Merck in 2026 for $6.7B.
Total Funding
$1.08B
Funding Rounds
6
Last Funding
Acquisitions
0
Monthly Visits
Contacts
58
About Terns Pharmaceuticals
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Foster City, California, United States
Terns Pharmaceuticals Funding Rounds
6 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Investor Names | Funding Stage | Org Industries | Org Hq City | Org Hq Country | Org Description | Org Number Of Employees | Org Website | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1–5 of 6Show
Page 1 / 2
Terns Pharmaceuticals Key People
Chief People Officer
Chief Medical Officer, Oncology
CLO
Chief Executive Officer
Chief Business Officer
Senior Vice President, Clinical Development & Operations
58
professional contacts at Terns Pharmaceuticals
Contact execs at Terns Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about Terns Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.